Accessibility Menu
InnovAge logo

InnovAge(NASDAQ) INNV

Current Price$11.56
Market Cap$1.57BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-52%
5 Year-33%
1 Year+204%
1 Month+20%
InnovAge last closing stock price
MetricPriceDate
Last closeUSD 11.562026-07-24
InnovAge stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.52%USD 11.502026-07-17
1 month+19.54%USD 9.672026-06-24
3 month+45.41%USD 7.952026-04-24
Year to date+122.74%USD 5.192025-12-31
1 year+204.21%USD 3.802025-07-24
3 year+59.45%USD 7.252023-07-25
5 year-32.56%USD 17.142021-07-23
Since inception-52.23%USD 24.202021-03-04

InnovAge Financials at a Glance

Market Cap

$1.57BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$945.90M

Net Income (TTM)

-$22.20M

EPS (TTM)

-$0.09

P/E Ratio

-133.80

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$11.56

Volume

0

Open

$11.07

Previous Close

$11.56

Daily Range

$11.07 - $11.71

52-Week Range

$3.13 - $12.64

Estimated Earnings Date

Sep 8, 2026

INNV News

Foolcom-Featured.png

InnovAge Revenue Jumps 11% in Fiscal Q4

Motley Fool Markets TeamSep 9, 2025
Women unhappy with body temperature reading

Why InnovAge Stock Dived by 11% Today

Eric VolkmanDec 27, 2021

INNV: Motley Fool Moneyball Superscore

52

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InnovAge

InnovAge helps older adults stay in their homes longer. It provides medical care, daily support, and transportation for seniors. Its services make independent living safer and easier for people with complex health needs.

What’s in the InnovAge Toolbox?

  • PACE Program (nearly all revenue): All-in-one care for seniors, including medical, therapy, and daily support, mainly for those eligible for Medicare and Medicaid.
  • In-Home Care: Skilled nursing, personal care, and help with daily activities for seniors at home.
  • In-Center Services: Primary care, therapy, dental, mental health, meals, and social activities at local centers.
  • Transportation: Rides to medical appointments and PACE centers for participants.
  • Pharmacy Services: Medication management and delivery, now supported by in-house pharmacy operations.

Growth Moves: InnovAge’s Expansion Playbook

  • Acquired two California PACE programs from ConcertoCare in 2023.
  • Bought pharmacy assets from Tabula Rasa Healthcare Group in 2025.
  • Formed a joint venture with Orlando Health in Florida in 2024.
  • Expanded to 20 PACE centers across six states by March 2025.
  • Invested in technology and compliance to support growth and efficiency.

Why InnovAge Stands Out in the Crowd

InnovAge is the largest provider of PACE services in the United States by participant count. It manages all aspects of care, taking on full financial risk for each participant’s health costs. Its recurring payments from government programs create a stable revenue base.

Five Things You Need to Know

  • Revenue was $218 million in Q1 2026, up 6.3% from Q1 2025.
  • Operating loss was $10 million in Q1 2026, compared to $5 million in Q1 2025.
  • Cash flow from operations was $25 million in Q1 2026, up from negative $8 million in Q1 2025.
  • InnovAge served about 7,530 participants at 20 centers as of March 2025.

Bottom Line

InnovAge has grown by expanding its PACE centers and acquiring new services. Its focus on comprehensive care for seniors positions it as a key player in managed senior healthcare.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,440

CEO

Patrick Blair, MBA

Website

www.innovage.com

Headquarters

Denver, CO 80230, US

INNV Financials

Key Financial Metrics (TTM)

Gross Margin

20.75%

Operating Margin

3.91%

Net Income Margin

-2.35%

Return on Equity

-9.20%

Return on Capital

-8.86%

Return on Assets

-4.06%

Earnings Yield

-0.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.57BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

135.74M

Volume

0

Avg. Volume

353.94K

Financials (TTM)

Gross Profit

$196.25M

Operating Income

$37.01M

EBITDA

$4.36M

Operating Cash Flow

$50.26M

Capital Expenditure

-$11.39M

Free Cash Flow

$38.87M

Cash & ST Invst.

$138.60M

Total Debt

$93.85M

InnovAge Performance Analysis

InnovAge annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 698,640,000N/A
20232023-06-30USD 688,087,000-1.5%
20242024-06-30USD 763,855,00011.0%
20252025-06-30USD 853,699,00011.8%
InnovAge sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30N/A
Q12025-09-308.2%
Q22025-12-311.5%
Q32026-03-315.1%
InnovAge annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -0.05N/A
20232023-06-30USD -0.30523.7%
20242024-06-30USD -0.16-47.7%
20252025-06-30USD -0.2242.6%
InnovAge sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-305.0%
Q12025-09-30N/A
Q22025-12-31197.4%
Q32026-03-31-382.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$251.94M

+15.5%

Gross Profit

$56.20M

+37.9%

Gross Margin

22.31%

N/A

Market Cap

$1.57BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$643.08K

N/A

Employees

2,440

N/A

Net Income

-$29.46M

-158.9%

EBITDA

-$23.96M

-430.7%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$138.60M

+36.2%

Total Debt

$93.85M

-11.0%

Accounts Receivable

$31.97M

-33.0%

Inventory

$0.00

N/A

Long Term Debt

$81.51M

+138.0%

Short Term Debt

$12.34M

-82.7%

Return on Assets

-4.06%

N/A

Return on Invested Capital

10.53%

N/A

Free Cash Flow

$14.61M

-32.7%

Operating Cash Flow

$18.22M

-26.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CMPSCOMPASS Pathways plc
$11.26-3.84%
AMNAMN Healthcare Services, Inc.
$32.89-0.54%
SNDASonida Senior Living, Inc.
$41.69+3.78%
SIBNSI-BONE, Inc.
$16.62+0.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.00-0.03%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$31.27-0.14%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.79+0.04%

Questions About INNV

What is the current price of InnovAge?

InnovAge is trading at $11.56 per share.

What is the 52-week range for InnovAge?

Over the past 52 weeks, InnovAge has traded between $3.13 and $12.64.

How much debt does InnovAge have?

As of the most recent reporting period, InnovAge reported total debt of $93.85M.

How much cash does InnovAge have on hand?

InnovAge reported $95.55M in cash and cash equivalents in its most recent financial results.

What is InnovAge’s dividend yield?

InnovAge does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services